Comparative in Vivo Stability of Copper-64-Labeled Cross-Bridged and Conventional Tetraazamacrocyclic Complexes

Medicine & Life Sciences

• Cyclams 100%
• Copper-64 94%
• (4,11-bis(carboxymethyl)-1,4,8,11-tetraazabicyclo(6.6.2)hexadecane)copper(II) 74%
• cyclam 67%
• cyclen 60%
• Chelating Agents 58%
• Acids 39%
• Copper Radioisotopes 38%
• Radioisotopes 35%
• Copper 34%
• n-tetradecane 32%
• 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid 29%
• n-hexadecane 28%
• ethylene 23%
• Radiopharmaceuticals 20%
• Proteins 19%
• Diagnostic Imaging 17%
• Radio 17%
• Metals 15%
• Radiotherapy 12%
• Liver 8%
• (4,10-bis(carboxymethyl)-1,4,7,10-tetraazabicyclo(5.5.2)tetradecane)copper(II) 5%

Chemical Compounds

• Chelating Agent 37%
• Radionuclides 30%
• Tetradecane 18%
• 1,4,8,11-tetraazacyclotetradecane 18%
• Acid 18%
• 1,4,7,10-tetraazacyclododecane 18%
• Hexadecane 16%
• Radiopharmaceutical 15%
• Radioisotope 14%
• Protein 10%
• Pharmacological Metabolism 10%
• Metabolite 9%
• Molecule 9%
• Metal 5%
• Application 4%